Back to top
Zalari has raised $2 million USD in a founding round led by Nyamaropa Technologies
Supreme Court

National Pharmaceutical Company v Drax Consult SAGL

SC 66/23

Case Details

Court
Supreme Court
Date
6 July 2023
Citation
SC 66/23
Neutral Citation
[2023] ZWSC 66
Outcome
unknown
Case Type
Appeal

Bench

Presiding
CHIWESHE JA
Full Bench
BHUNU JACHIWESHE JAMUSAKWA JA
Areas of Law
Arbitration LawPublic Procurement LawContract Law
Keywords
arbitral awardpublic policyPRAZ approvalprocurement contract
Tags
arbitrationpublic procurementcontract legality
legislation
Statutes Cited
  • Public Procurement and Disposal of Public Assets Act
  • Arbitration Act
  • Public Procurement and Disposal of Public Assets Act
ai analysis
Case Summary

Key Issues

  • {"issue_text":"Whether the contract of procurement was approved by PRAZ in terms of s 15(1) of the Act","issue_type":"mixed","dispositive":"yes","related_facts":"6 November 2019 letter from PRAZ CEO, contract formation, arbitration award"}
This summary was generated by AI. Use Zalari to read the full judgment.
background
Facts of the Case

Background

The appellant, a Zimbabwean state-owned pharmaceutical company, entered into a procurement contract with the Swiss respondent for medical supplies. After receiving most supplies, the appellant refused to pay US$210,000 worth, claiming the contract lacked required PRAZ approval under s 15 of the Public Procurement Act. Arbitrators declared the contract illegal, but the High Court set aside this award as contrary to public policy, finding PRAZ had in fact approved the contract through a 6 November 2019 letter.
Read the full judgment, get AI analysis, and find related cases
Open in Zalari →